Oragenics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.56

+0.06 (+11.27%)

As of Mar 31, 5:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +816.9% upside

Low Target $3.59

Average Target $5.14

High Target $6.80

Current Price $0.56

Current
$0.56

Target
$5.14

$3.59 $5.14 avg $6.80

Scenario Analysis

Bear Case

$3.59

540.4%

Low target

Base Case

$5.14

+816.9%

Avg target

Bull Case

$6.80

+1,113.0%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$9.60

-94.2% from high

52-Week Low

$0.58

+-2.7% from low

Target vs 52W High

$5.14

-46.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%